Avenue Therapeutics, Inc. (ATXI) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for ATXI is $12.00, representing a +2,252.9% upside from the current price of $0.51. Price targets range from a low of $12.00 to a high of $12.00.
